As per the decision of the Capital Markets Board (the “CMB”) numbered 68/2461 and dated 30 December 2025, published in its bulletin dated 31 December 2025, the financial thresholds required for the companies’ initial public offering have been increased. Accordingly, the required minimum total assets amount in the financial statements has been revised to TRY 2,400,000,000 for 2024 and to TRY 3,600,000,000 for 2025 and the minimum net sales revenue amount has been revised to TRY 1,200,000,000 for 2024 and to TRY 1,800,000,000 for 2025 in order for companies to be eligible to apply for public offering.
Also, the minimum capital amount required for transition to the registered capital system has been increased to TRY 200,000,000.
The CMB, through its decision numbered 18/505, published in its weekly bulletin dated 28 March 2024, and numbered 2024/17, had decided to reduce the public offering financial thresholds in relation to total assets and net sales revenues, limited to companies operating in the energy, chemical, agriculture, and defence industries, as well as those providing advanced technology-based solutions.
For the year 2026, the CMB continues to implement sector-specific public offering facilitation measures. The financial thresholds applicable to companies within the scope of decision numbered 18/505 have been revised as follows:
| TRY | For the Year of 2024 | For the Year of 2025 |
| Net Sales Revenue | 600,000,000 | 900,000,000 |
| Total Assets | 1,200,000,000 | 1,800,000,000 |
Share
Related persons
You can contact us for detailed information.




Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
16 January 2026
Employment Law Developments in Türkiye: 2025 Highlights and a Look Ahead to 2026
2025 brought significant developments in Türkiye’s employment laws, driven by regulatory changes and influential court decisions affecting…
2 January 2026
Legal Developments Regarding the Use of Cannabis for Medical Purposes in Türkiye
Legal Developments Regarding the Use of Cannabis for Medical Purposes in Türkiye
10 December 2025
Protecting Those Who Speak-Up: Whistleblowing and Retaliation under Turkish Law
This article focuses on the protections available to whistleblowers in Türkiye from an employment law perspective, and on the legal risks…
28 November 2025
Turkish Competition Law Newsletter – 2025 Autumn Issue
Turkish Competition Law Newsletter - 2025 Autumn Issue
21 November 2025
Recent Developments in Healthcare Legislation
New Guideline on the Applications for GMP Inspections of Foreign Manufacturing Facilities. The Guideline on the Applications for GMP…
18 November 2025
A New Risk for Turkish Companies: The UK Offence of ‘Failure to Prevent Fraud’
The Economic Crime and Corporate Transparency Act 2023 (“ECCTA”), a landmark piece of legislation in the United Kingdom’s (the “UK”)…